This report provides comprehensive insights on the drug discovery outsourcing global market.

BOSTON, MASSACHUSETTS, U.S.A, June 27, 2017 /EINPresswire.com/ -- This report provides comprehensive insights on the drug discovery outsourcing global market. The report covers all segments, global trends and emerging strategies of the outsourcing market related to drug discovery. Major Drug Discovery Outsourcing (DDO) players included in the report are Advinus, AMRI, Aurigene, BioDuro, Charles River Laboratories (CRL), Chem Partner, Evotec, GVK Biosciences, Jubilant, Pharmaron, Shanghai Medicilon, Sundia Meditech, Syngene, TCG Lifesciences and Wuxi Apptec.

This report caters to the need of Contract research organizations, Pharmaceutical/Biotech companies, Academic institutes, Individual researchers, Investors, Service providers and other associated stake holders to identify and analyze the potential of the DDO market. The report also provides insights on customer base, number of deals between CRO’s and Pharmaceutical /biotech firms, global FTE rates, employee strength & number of companies, revenue per employee of major players, therapeutic area gap analysis and successful research collaboration outcomes of selected CRO’s and Sponsors, which are likely to have an impact on the DDO market in the foreseeable future.

This report covers in-depth analysis of major players by therapeutic area of focus, capabilities, geographic presence, business models, financials, collaborations, acquisitions, various marketing strategies adopted along with insightful analysis on conferences, clusters and match making websites.

Mr. Sattish Biruddukota
IQ4I Research & Consultancy Pvt Ltd.,
+91-80-60500229
email us here